SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: smh who wrote (3602)4/26/2001 9:56:15 PM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 52153
 
<<You are a hard man MZ :-)).>>

Thanks! -)

For BT-sector very few analyst can project with good handling success/failure of the end-stage drug candidates, not to mentioned early PIb/IIa stage. So analysis is simple hype (dictated from bankers) or next 1-2 Q view, at the best. More than that is asking too much.

When JC speak about pharma/bios it is none of this, it is cretinism, at the best. AIMHO.

Miljenko


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News